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INTRODUCTION 
As it stands, science has not yet come to fully understand the mechanisms 
of mammalian reproduction.  However, what has become quite evident, as a result 
of research, is that certain components of female reproduction are very important. 
The production of female germ cells, known as oocytes in Mus musculus (mice), 
through the formation of a pool of primordial follicles, before birth, is one such 
integral component (Pepling and Spradling, 1998).  The pool of primordial 
follicles is essential to reproduction in that it is the complete amount of oocytes 
that a female will have available for fertilization for the rest of her life.  Thus, it is 
important to understand how primordial follicles are assembled and what intrinsic 
and extrinsic influences affect their formation.  Developing a better understanding 
of the formation of these follicles gives scientists further insight into female 
sexual maturation and the problems that may arise within it. 
 The importance of the primordial follicle is also evident as it is the first 
step in the ovarian cycle.  This cycle is a process involving the enlargement and 
maturation of a group of follicles until they are ready to be ovulated (Dean and 
Epifano, 2002).  It begins with a primordial follicle, which is one oocyte 
surrounded by a single layer of flattened granulosa cells that support its growth. 
The follicle continues to develop until it becomes a primary follicle.  Primary 
follicles are denoted by a larger oocyte encased in an increased number of 
granulosa cells that have become more cuboidal in shape.  The primary follicle 
then matures into the secondary follicle.  Likewise, the secondary follicle is much 
larger than its precursor, but is now surrounded by more than one layer of 
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granulosa cells.  The oocyte is then surrounded by an extra-cellular matrix called 
the zona pellucida that contains proteins that will later allow penetration of sperm.  
The granulosa cells then become surrounded by a layer of stromal-like theca cells 
that differentiate into the theca externa and interna.  A network of capillaries 
becomes embedded between these two layers. Few oocytes survive beyond this 
point in the cycle.  Most oocytes become atretic and die, due to either oocyte or 
granulosa cell apoptosis (Hsu and Hsueh 2000). The survivors continue to grow 
into tertiary follicles, also known as antral or Graafian follicles.  These pre-
ovulatory follicles contain a fluid-filled space called an antrum containing 
proteins, hormones and other molecules that support the follicle’s continued 
growth.  This follicle continues to mature until expelled from the ovary as an egg 
during ovulation, to possibly be fertilized.  The remains of the follicle become the 
corpus luteum, which secretes hormones that support pregnancy, but if the egg is 
not fertilized within 14 days this turns into the corpus albicans. 
The pool of primordial follicles is formed from the oocyte precursor cells 
called primordial germ cells (Figure 1).  Initially, within the developing mouse 
embryo, primordial germ cells migrate to the gonads.  By approximately 10.5 
days post coitum (dpc) the primordial germ cells have arrived at the gonad, 
divided mitotically, and between 10.5 dpc and 13.5 dpc clusters of cells called 
germ line cysts form.  The oocytes in these cysts are connected via intercellular 
bridges that formed as a result of incomplete cytokinesis (Pepling and Spradling 
1998).  The germ cells enter meiosis at 13.5 dpc and are now considered oocytes. 
The oocyte cysts persist until birth.  Following birth, these clusters begin to break 
 3 
apart in a process coined cyst breakdown (Pepling and Spradling 2001).  After the 
disassembly of the cysts, individual oocytes eventually become primordial 
follicles. 
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Figure 1.  Timeline of Germ Cell development in Mice (adapted from Pepling, 
Spradling, 2001).  Yellow cells are oocytes and the red cells are granulosa cells. 
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Although the process of cyst breakdown is not yet fully understood, it is 
clear that apoptosis, or programmed cell death occurs simultaneously and may be 
integral to mammalian reproduction (Pepling and Spradling, 2001).  As a result of 
germ cell death, approximately two thirds of the oocytes present before birth do 
not survive (Pepling and Spradling 2001).  According to the model of cyst 
breakdown, dying cells disrupt the intercellular bridges (Figure 2).  These breaks 
diminish the size of the cyst until only a few oocytes remain.  It is not known why 
these cells die or which cells will undergo apoptosis.  However, it has been 
postulated that the cells that die serve as nurse cells for the oocytes that survive.  
Nurse cells are cells that provide nutrients to the developing oocyte (Mahajan-
Miklos and Cooley, 1994).  For example, the Drosophila ovary contains 16-cell 
cysts, only one cell in each cyst becomes an oocyte and the other 15 become nurse 
cells. These cysts are formed from stem cells that create cystoblasts that divide 
exactly four times mitotically and form interconnected cellular bridges by 
incomplete cytokenesis. Within these cysts, the nurse cells eventually die by 
apoptosis. Overall, it seems apparent that for the primordial follicle formation in 
mice requires cyst breakdown and simultaneous apoptosis is imperative.  
 
 Figure 2.  Model of Cyst Breakdown (Pepling and Spradling, 2001).  The 
breakdown of an 8 cell cyst.  The green cells are apoptotic (dying) and their 
death result in the disassembly of the cyst. The process ends in the formation 
of single oocytes that will later become surrounded by granulosa cells to 
become primordial follicles. 
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Cell death and follicular development have been found to be regulated by 
steroid hormones such as estrogen (Manglesford et al., 1995, Findlay 1993).  
Estrogen is of particular interest in this case because of its extensive impact on 
female sexual development.  This hormone is known to have an effect on female 
sex determination, reproduction, and pregnancy (Kos et al., 2002).  Thus, it would 
not seem improbable for it to also have a role in cyst breakdown and the 
subsequent maintenance of follicular maturation.  
  Estrogen is a steroid hormone.  Though it is most active in females, it is 
also known to play critical roles in male sexual development.  It is also active in 
other bodily functions, such as bone metabolism, and cardiovascular and neuronal 
activity (Kos et al., 2002).  The hormone is produced by the ovaries, adrenal 
glands, and testes.  There are three major forms of estrogen active in females 
called estradiol, estrone, and estriol.  Within the ovary, estrogen production is 
initiated by developing follicles and the secretion of follicle stimulating hormone 
(FSH) and luteinizing hormone (LH).  The process begins with the formation of 
androstenedione from cholesterol in the theca cells, which are cells that line the 
outside of the granulosa cells.  From here this precursor hormone is transported to 
the granulosa cell where it is later converted to some form of estrogen, either 
estradiol or estrone, via the enzyme aromatase (Kato et al., 1995).  
 The estrogen hormone signals cells through receptor-mediated pathways. 
Research has shown that aberrations in this signaling during development can 
lead to multiple and long-term abnormalities in the reproductive system (Jefferson 
et al., 2002).  Estrogen first maneuvers through the cell membranes, probably by 
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diffusion, and comes into contact with an estrogen receptor in the nucleus of the 
cell (Figure 3).  Estrogen has two receptors, estrogen receptor alpha (ERα) and 
estrogen receptor beta (ERβ) (Krege et al., 1998).  These receptors are part of the 
steroid nuclear receptor superfamily.  ERα and ERβ are classified as ligand-
dependent transcription factors whose ligands are either estrogen or estrogen-like 
compounds (Mathews and Gustafsson, 2003).  These receptors are known to 
homodimerize once activated.  Once estrogen binds to these receptors, the ligand-
receptor complex interacts with a special portion of the DNA present in target 
genes called an estrogen response element (ERE).  After recruiting co-regulators 
and other transcription factors, the target genes are then activated, producing 
proteins that go on to elicit pleiotropic effects within the organism. 
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ERα and ERβ are both important for estrogen signaling.  Initially, 
scientists believed that estrogen signaling was only carried out through ERα, but 
Figure 3.  Estrogen Signaling Pathway. Estrogen binds to the receptor protein. 
The receptor protein then homodimerizes and bind to estrogen response 
elements on target genes. 
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the discovery of ERβ and the divergence of the two receptors’ expression patterns 
implies that they may affect reproductive development quite differently (Jefferson 
et al., 2002).  ERα is expressed in many parts of the body including the liver, 
kidney, heart, and ovary (Matthews and Gustafsson, 2003).  Within the adult 
ovary ERα is expressed in the theca and interstitial cells (Couse et al., 1999).  
However, its expression in the neonatal ovary is unknown.  ERβ is mainly 
expressed in the ovary, prostate, epididymis, lung, and hypothalamus (Krege et 
al., 1998).  ERβ is expressed in the granulosa cells of the ovary and has been 
detected in neonatal ovaries by RNase protection (Jefferson et al., 2000).  Though 
ERα is slightly bigger than ERβ, they both have six protein domains (A-F) and 
share similar protein domain composition (Figure 4).  In both receptors, a ligand-
independent transactivation function called AF-1 is present in the A/B domain of 
the N-terminus (Hewitt and Korach, 2002).  AF-1 along with AF-2, a C-terminal 
ligand-dependent activation function found in the E domain, assists with estrogen-
mediated transcription and cell- and promoter-specificity (Mattews and 
Gustafsson, 2003).  Domain C is highly conserved; it is responsible for specific 
binding to estrogen response elements on the DNA and for receptor dimerization. 
The ligand binds to the receptor protein at the E domain, which is less conserved 
and partially responsible for dimerization (Dupont and Krust, 2000).  
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 Mutations within both the ERα and ERβ receptors can lead to severe 
dysfunction in the adult mouse ovary.  Each receptor has been knocked out by 
insertion of the neomycin gene into important coding exons (Kos et. al., 2002). 
Adult female ERβ knock out (ERβKO or ERβ-/-) mice display smaller litters as a 
result of reduced fertility.  In these knockout mice there was a decreased number 
or absence of corpora lutea, though the ovaries looked fairly normal with normal 
antral follicles (Dupont and Krust, 2000).  
 In adult female ERα-/- mice the phenotypic abnormalities are more severe. 
These mice display abnormalities in the reproductive tract, gonads, skeletal and 
cardiovascular systems.  ERα-/- females have normal follicles until the antral 
stage.  However, adults later lack corpora lutea and have cystic and hemorrhagic 
follicles (Emmen et. al., 2007).  Many follicles are atretic. ERα-/- mice do not 
ovulate and are thus sterile.  There is also an increase in the amount of LH 
circulating in ERα-/- females (Rosenfeld et al., 2000). Increased amounts of 
Figure 4.  ERα and ERβ Functional Protein Domain Composition (adapted 
from Klinge, 2000). The amino acid length is indicated at the beginning 
and end of each domain. Domains C and E are the most homologous (97% 
and 55% respectively).   
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hormones can alter follicle development.  Even after being treated with exogenous 
gonadotropins, the anovulation phenotype could not be reversed in adult mice 
(Couse and Korach, 1999).  This suggests that the hormonal imbalance, coupled 
with the defective ERα receptor has irreversible and more severe effects on the 
adult ovary than ERβ-/-.   
Although research on both receptors has yielded important information, 
further inquiry into ERα is still necessary when it comes to neonatal mice.  In a 
study done using neonatal mouse ovaries grown in organ culture, estradiol 
treatment inhibited cyst breakdown and primordial follicle formation, but did not 
influence oocyte survival (Chen et. al., 2007).  In addition, ERα and ERβ receptor 
specific agonists cause delays in cyst breakdown (Chen and Pepling, in 
preparation).  In adult mice, immunohistochemistry has revealed that ERα is 
expressed in the interstitial and theca cells of rats, mice, cows, and humans 
(Couse et. al., 1999).  ERα has also been detected in the human ovary (Couse and 
Korach, 1999).  However, it is not known where or if ERα is present in the 
neonatal mouse ovary.  The focus of my research is thus to explore the expression 
of ERα in neonatal mice.  This study has two goals: 1) determining where ERα is 
normally expressed in neonatal ovaries; and 2) discovering what happens to 
oocyte development when ERα protein expression is disrupted by examining mice 
for defects in primordial follicle formation, cyst breakdown, and oocyte survival. 
The results of this research will add substance to what is already known about 
estrogen signaling and possibly shed some light on sterility in mice that may be 
applied to humans in later studies. 
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MATERIALS AND METHODS 
 
Animals 
  The mouse strain lacking ERα used in this study was obtained from 
Jackson Laboratories.  In this strain, homologous recombination had been used to 
insert a neomycin resistance gene into exon 2 of the ERα gene, disrupting its 
function (Lubahn et al., 1993).  The mice are maintained as ERα+/- heterozygotes.  
To obtain neonatal mice for analysis, matings were set up between two 
heterozygous ERα+/- mice. For four days following mating, mice were checked for 
vaginal plugs, which would indicate pregnancy.  On the day that a female displays 
a plug she is isolated and the day is denoted as 0.5 days post coitum (dpc).  Birth 
usually occurs at 19.5 dpc. This day is then denoted post natal day 1 (PND1).  
Neonatal ovaries were harvested from PND1, PND4 and PND7 offspring.  
Ovaries were also collected from the CD-1 strain of mice (obtained from Charles 
River Laboratories) at various ages for Western blotting and 
immunocytochemistry using an antibody against the ERα protein. 
 
Purification of DNA from Mouse Tails 
 Each mouse was given a metal numerical tag.  A piece of tail was then 
collected and placed in a centrifuge tube marked with the mouse’s identification 
number.  The DNA was isolated from tissue via the DNAeasy kit (QIAGEN).  
180 microliters (µl) of Buffer AL and 20 µl of the enzyme proteinase K were then 
pipetted into each tube.  This solution was placed in a 55˚C water bath for at least 
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six hours and then vortexed.  A one to one mixture of Buffer ATL and 100% 
ethanol was prepared. 400 µl of the mixture was added to each sample and then 
vortexed.  The samples were then transferred into spin columns with collection 
tubes attached, to which 500 µl of AW1 buffer plus ethanol was added.  The tubes 
were centrifuged at 8,000 rpm for one minute.  The collection tubes were 
discarded and replaced.  Then 500 µl of AW2 buffer plus ethanol was added to 
each tube and centrifuged at 14,000 rpm for three minutes.  The collection tubes 
were discarded and replaced, this time with new centrifuge tubes.  To elute the 
DNA, 100 µl of AE buffer was added to each of these tubes and centrifuged at 
8,000 rpm for one minute.  Lastly, the DNA was stored at -20˚C to keep it from 
degrading. 
 
Polymerase Chain Reaction (PCR) 
 PCR amplification was used to determine the genotypes of offspring 
obtained from crosses of ERα+/- mice.  To do this two reactions were used; an A 
reaction to amplify the wildtype allele and a B reaction to amplify the mutant 
allele.  The A reaction mixture consisted of 4.5 µl, 1 µl of 2/FOR primer, 2.5 µl of 
2/REVII primer and, 7 µl of Red Taq (Sigma) polymerase.  The B reaction 
mixture consists of 6 µl of distilled water, 4 µl of 1.25 mM dNTP mixture (1.25 
mM of each of dATP, dTTP, dCTP, and dGTP), 2.5 µl of 10X Buffer A, 1 µl 
each of primers 13 and 14, and 0.5 µl of Taq polymerase (Fisher).  The sequences 
of the primers are as follows:  
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Primer 2/FOR: 5’-CTGTGTTCAACTACCCCGAGG 
Primer 2/REV II: 5’-GGCGCGGGTACCTGTAGAA 
Primer 13: 5' CTT GGG TGG AGA GGC TAT TC-3' 
Primer 14: 5'AGG TGA GAT GAC AGG AGA TC-3' 
                         P1           P2 
 
 
 
 
 
          P1              P3    P4      P2 
                         
 
 
 
 
In the A reaction, primers 2 FOR and 2 REV II amplify a 327 base pair 
DNA fragment from the wildtype allele. In the B reaction, primers 13 and 14 
amplify a 290 base pair DNA fragment from the targeted allele, amplifying the 
neomycin insertion.  Using wildtype DNA, only the 327 base pair fragment is 
amplified.  Using heterozygous (ERα+/-) mice, both the 327 and 290 base pair 
fragments are amplified.  Using a (ERα-/-) mouse only the 290 base pair fragment 
is amplified. 
EXON 2 EXON 3 
EXON 3 2 2 
NEO 
EXON 3 2 2 NEO 
Figure 5.  Primers 1 and 2 anneal to Exon 2 of the ERα gene. A neomycin insertion 
is placed into Exon 2 to create the mutant allele (Jackson Laboratories) and primers 
3 and 4 amplify the insert.  
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The total volume in each reaction tube was 15µl.  Both tubes were then 
placed in the thermocycler on the following ERα programs: 
A Reaction: 
 Stage: 1 Step: 1  2 minutes at 95˚C 
Stage: 2 Step: 1  45 seconds at 54˚C 
Step: 2  45 seconds at 72˚C 
Step: 3  45 seconds at 72˚C 
(Stage 2 repeated for 35 cycles) 
Stage: 3 Step: 1  7 minutes at 72˚C 
(Hold at 4˚C) 
 
B Reaction: 
 Stage: 1 Step: 1  3 minutes at 95˚C 
Stage: 2 Step: 1  30 seconds at 94˚C 
Step: 2  1 minute at 64˚C 
Step: 3  90 seconds at 72˚C 
(Stage 2 repeated for 35 cycles) 
Stage: 3 Step: 1  2 minutes at 72˚C 
(Hold at 10˚C) 
 
Gel Electrophoresis 
 Gel electrophoresis was used to determine the size of each PCR product.  
To do this, a 2% agarose gel was prepared.  To make the gel, 50 ml of 1X TBE 
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buffer and 1 gram of agarose were placed into a 125 ml Erlenmeyer flask and 
microwaved for 2 minutes.  The flask was mixed every 40s so the agarose would 
dissolve properly. 2.5 µl of 10 mg/ml ethidium bromide was added to the hot 
mixture and swirled for even distribution.  The gel was then poured into a gel 
tray, equipped with a comb to create individual wells.  The gel was then left to 
cool for 10-15 minutes.  After the gel had solidified, the gel tray was placed into a 
gel box and 1X TBE buffer was poured over it until the gel was completely 
submerged.  The comb was removed.  A mixture of 2 µl of 6X loading dye and 10 
µl of each PCR product was loaded into each well.  2 µl of 6X loading dye, 5 µl 
of 100 bp marker, and 5 µl of 1X TBE buffer were loaded into a well to serve as a 
base pair marker, for band size reference.  The gel box was then covered and run 
at approximately 100 volts for one hour.  Kodak Image Station software and UV 
detection were then used to take an image of the gel and to analyze the 
amplification products. 
 
Dissection 
 Neonatal ovaries were harvested from both CD1 and ERα mice at PND1, 
PND4, and PND7.  The ovaries were harvested in 1X phosphate buffered saline 
(PBS) using a dissecting microscope.  For analysis of ERα mice, a portion of the 
tail of each mouse was also collected and placed in a separate tube to be 
genotyped. 
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Whole Mount Antibody Staining of Neonatal Ovaries 
 For analysis of ERα mutant mice, ovaries were dissected and placed into 
tubes containing 600 µl of fixative, which consisted of 400 µl of 1XPBS and 200 
µl of 16% formaldehyde (Ted Pella Inc.), for a final concentration of about 5.3% 
formaldehyde.  Each of these tubes was labeled according to genotype: wildtype 
(ERα+/+), heterozygous mutant (ERα+/-), and homozygous mutant (ERα-/-).  Each 
tube was then nutated overnight at 4˚C. The ovaries were quickly washed two 
times in 1 ml of PT and then a third time in 1 ml (PBS/Triton) PT for at least 30 
minutes at room temperature.  The ovaries were incubated in PT + 5% bovine 
serum albumin (BSA) for 30- 60 minutes on a room temperature nutator.  The 
ovaries were then incubated with 2.5 µl of primary antibody against the oocyte 
marker Stat3 (C20) (Santa Cruz Biotechnology), in 500 µl of PT + 5% BSA 
overnight at 4˚C on a nutator (Murphy et al., 2005).  They were washed in 1 ml 
PT + 1% BSA for 30 minutes at room temperature.  Then the ovaries were 
incubated in 10 µl of 10 mg/mL RNase A in 1 ml PT +1% BSA for 30 minutes at 
room temperature.  The ovaries were incubated in 10 µl of 5 µg/ml propidium 
iodide in 1 ml of PT + 1% BSA for 20 minutes at room temperature.  Propidium 
iodide was used as a nuclear marker.  At this point each tube was wrapped in 
aluminum foil to preserve fluorescence.  The ovaries were washed in 1 ml PT 
+1% BSA for 30 minutes at room temperature.   
 The secondary antibody anti-rabbit Alexa 488 (Molecular Probes) was 
prepared a day in advance. It was first pre-absorbed by making a 1:200 dilution of 
2.5 µl of antibody in 500 µl of PT + 5% BSA and a small amount of embryo 
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powder.  Embryo powder is a dried mixture of homogenized mouse embryos at 
ages 12.5-14.5 dpc.  This mixture was then wrapped in aluminum foil and placed 
on a 4˚C nutator overnight.  The ovaries were then incubated in this pre-absorbed 
secondary antibody for 2-4 hours on a room temperature nutator.  Next, the 
ovaries were washed three times in 1 ml of PT + 1% BSA for 30 minutes each 
time on the nutator at room temperature.  They were washed once quickly in 1X 
PBS.  The PBS was then removed, 100 µl of Vectashield (Vector Laboratories) 
was added to each tube and incubated for 15 minutes.  The ovaries were then 
mounted on a slide, with a cover slip and stored at -20˚C. 
 Antibody staining of neonatal CD1 mice at PND1, PND4, and PND7 was 
also done to determine the localization and expression of the ERα protein.  The 
anti-ERα MC-20 (Santa Cruz Biotechnology) antibody was used as a primary 
antibody at 1:100 dilution in this portion of the study.  The same Alexa Flour® 
488 Goat Anti-rabbit IgG (H+L) (Molecular Probes) described above was used as 
a secondary antibody at a 1:200 dilution. 
 
Confocal Microscopy 
 The collected and stained PND1, PND 4, and PND7 ovaries were 
observed via indirect immunofluorescence with the Zeiss Pascal confocal 
microscope.  The images obtained were used to analyze cyst breakdown, follicle 
development and oocyte number. PND7 ERα+/+ images were obtained from the 
work of a previous undergraduate in our lab. Eight optical sections were taken per 
ovary. Images were obtained from four optical planes at sites at least 5 µm apart 
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(8 sections in all).  Oocyte number was determined by adding the total number of 
oocytes in each optical section.  Cyst breakdown was assessed by counting the 
number of single oocytes and comparing that the number to the number of 
oocytes still in cysts.  For this, a stack of ten slices was taken for each of the eight 
sections to determine if oocytes were connected in cysts outside of the plane of 
focus. Each stack consisted of five images above and below the section being 
examined; each image was 1 µm apart from the next.  Follicle development was 
determined by counting how many oocytes were at each stage of development in 
each of the optical sections.  If there were no oocytes or follicles in a sample it 
was not counted in the average. Oocytes were considered unassembled if 
granulosa cells did not completely surround the oocyte.  Single oocytes, 
completely surrounded by granulosa cells, were classified as primordial, primary, 
or secondary.  Primordial oocytes were surrounded by a single layer of flattened 
granulosa cells.  Primary oocytes were surrounded by one layer of granulosa cells 
that are cuboidal in shape.  Secondary oocytes, considerably larger, were 
surrounded by more than one layer of cuboidal granulosa cells.   
 One-way ANOVA was conducted to look at differences between wildtype 
and mutant ovaries for oocyte number, cyst breakdown, and follicle development. 
PROC GUM of SAS 9.1 (SAS Institute Inc., Cary, NC) was used to calculate the 
least square means and test specific hypotheses for effects. A p value < 0.05 was 
considered significant. 
 
Western Blotting  
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 Western Blotting was utilized to determine if the ERα protein was 
expressed in different tissue samples.  Ovaries at PND1, PND4, PND7, PND42, 
and PND 108 were dissected in 1X PBS and immediately stored on ice.  Ovary 
extracts were made by homogenizing the ovaries in 10 µl of 1X sample buffer per 
ovary.  1X sample buffer is a mixture of 500 µl of 2X sample buffer, 100 µl of 
10X stock of protein inhibitor, and 400 µl of distilled water.   2X sample buffer 
consists of 4 ml of 10% SDS, 2 ml of glycerol, 1ml of 0.1% bromophenol blue, 
2.5 ml of 0.5 M tris (pH 6.8), and 0.5 ml of 2-mercaptoethanol.  The proteinase 
inhibitor stock was made by dissolving one tablet of mini complete protease 
inhibitor (Roche Diagnostics) into 1 ml of distilled water.  20 µl of each ovary 
extract is placed into a boil-proof tube and 2 µl of 2-mercaptoethanol was then 
added to each.  20 µl of MCF-7 whole cell lysate (Santa Cruz) was used as a 
positive control. MCF-7 cells are taken from human breast adenocarcinoma cell 
lines and are positive for estrogen receptors (Mairesse et al. 1980).  The tubes 
were then boiled for three minutes, cooled on ice, and then centrifuged at 6,000 
rpm for 1 minute.  
 A 4-20% polyacrylamide gel was placed in a western blot gel box that was 
approximately one-third full of with 1X SDS Running buffer.  The running buffer 
is made from 100 ml of a 10X stock plus distilled water to bring volume to 1 liter. 
The 10X Running Buffer contains 29g of Tris base, 144 g of glycine, 10 g of 
SDS, dissolved in 1 liter of distilled water.  20µl of each ovary extract sample was 
loaded into a well after the wells had been cleaned.  10 µl of Precision Plus 
Standard Protein marker (Bio-Rad) plus 10 µl of 2X sample buffer was added into 
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the first well as a reference for band size.  Gel electrophoresis was performed at 
100 volts for approximately 1 hour. 
Protein was transferred to a Polyvilnidene fluoride (PVDF) membrane 
(Millipore) as follows. A 6 x 8 cm piece of PVDF membrane was soaked in 
methanol for 1 minute and then washed in distilled water for 5 minutes.  The 
PVDF membrane and gel were then soaked in Transfer buffer for 5 minutes (in 
separate trays).  Simultaneously, two pieces of filter paper cut to the size of the 
gel and two fiber pads were also soaked in Transfer buffer for 5 minutes.  The 
Transfer buffer contains 3.0 g of Tris base, 14.4 g of glycine, and 200 ml of 
methanol in distilled water brought to a total volume of 1 liter and stored in a dark 
bottle at 4˚C.  All of the materials were placed in a transfer cassette, dark side (of 
the transfer cassette) down, in the following order: fiber pad, filter paper, gel, 
membrane, filter paper, fiber pad.  The transfer cassette was then inserted into the 
transfer casket with the black side of the cassette facing the black side of the 
casket.  A magnetic stir bar was then placed into the transfer unit.  The transfer 
casket was placed into the transfer unit, with the black side facing a pre-made ice 
cube.  The transfer unit was filled with Transfer buffer. The unit was placed at 
4˚C fridge and the transfer was performed at 100 volts for one hour. The gel was 
then stained with Coomassie Blue for 30 minutes to visualize whether the protein 
had run and for preservation. The gel was then washed with destain solution 
overnight.  The destain solution consisted of 450 ml of distilled water, 450 ml of 
methanol, and 90 ml of acetic acid.  The gel was dried on a glass frame and gel 
wrap.  The membrane was put into Blocking buffer in a tray on a shaker for 30 
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minutes at room temperature, the buffer was then changed and the membrane was 
stored at 4˚C overnight.  Blocking buffer contains 100 ml of 10X PBS 50 g of 5% 
nonfat dry milk, and 0.5 ml of 0.05% Tween 20 in distilled water brought to a 
volume of 1 liter. 
The membrane was then incubated in primary antibody diluted in 
Blocking buffer and placed on a nutator at room temperature for one hour.  ERα 
MC-20 (Santa Cruz) was used as the primary antibody at a concentration of 
1:500.  The membrane was washed in Blocking buffer for three 10 minute 
intervals on a shaker at room temperature.  It was then incubated in secondary 
antibody diluted in blocking buffer for one hour on a room temperature nutator. 
The secondary antibody used was goat anti-rabbit conjugated to horseradish 
peroxidase (HRP) (Jackson Immunolabs) in dilutions ranging from 1:10,000 to 
1:15,000.  
Following antibody treatment the membrane was then placed in Wash 
buffer for 10 minutes on a shaker at room temperature.  The Wash buffer contains 
0.05% Tween in 1X PBS.  The membrane was washed in 1X PBS, placed in a 1:1 
mixture of detection and enhancer solutions (Pierce), 5 ml per membrane, for 5 
minutes on the shaker, and then rinsed in distilled water.  A plastic pouch cut 
slightly larger than the PVDF membrane was then prepared and the membrane 
placed inside.  The plastic pouch was taped to a cardboard mount and exposed to 
autoradiography film to detect the ERα protein.  
The PVDF membrane was reprobed with the antibody against 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (EnCor Biotechnology 
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Inc.) as a loading control. The membrane was first rinsed in 1X PBS. It was then 
placed in a Blocking buffer for one hour on shaker at room temperature.  The 
same detection procedure was then followed using GAPDH at 1:500 as a primary 
antibody and anti-mouse-HRP (Santa Cruz) at 1:10,000 as the secondary 
antibody.   
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RESULTS 
 
Expression of ERα in Neonatal Mouse Ovaries 
Western blot analyses were carried out to detect the ERα protein in ovaries 
at several different ages (Figure 6).  Anti-ERα antibody, MC-20, was used at a 
1:500 dilution and the goat anti-rabbit was used as at 1:10,000 dilution.  ERα is 
known to have at least three splice variants corresponding to proteins of 66, 55, 
and 46 kDa (Pendaries et al., 2002).  MCF7 cell lysate, containing a human ERα 
protein taken from human breast adenocarcinoma lines was used as a positive 
control.  A band at 46 kDa corresponding to ERα protein was detected in the 
positive control.  Bands at 66 kDa and 55 kDa were detected for PND1, 4, and 7 
wildtype mice.  PND 108 displayed bands at 66 kDa, 46 kDa, and 30 kDa.  The 
ERα MC-20 antibody is directed toward the C-terminal portion and will detect all 
three ERα isoforms (66 kDa, 55 kDa, and 46 kDa).  The blot was reprobed with 
GAPDH as a loading control. 
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A.                                                                                            
                                                     
B.  
             
 
 
  
 
 
Figure 6.  Western Blot Analysis of ERα Protein. A. MCF7 whole cell 
lysate purified from human breast adenocarcinoma lines was used as a 
positive control. Tissue extracts from wildtype CD-1 mice at PND1, 
PND4, PND7, PND108 were probed with ERα MC-20 antibody. B. Blots 
were reprobed with GAPDH.   
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An additional Western blot was run with PND1, PND4, PND7, and 
PND42 ovary extracts from wildtype CD-1 mice.  ERα MC-20 was kept at the 
same concentration as the previous blot, but the goat anti-rabbit secondary 
concentration was adjusted to 1:15,000 in an effort to reduce background.  Three 
PND42 extracts were used to detect the difference in expression of the ERα 
protein in ERα+/+, ERα+/-, and ERα-/- mice. Results from the Western blot indicate 
66 kDa and 55 kDa isoforms are present at PND1 and PND4 (Figure 7).  The 66 
kDa isoform was detected at PND7.  All three of the PND42 extracts contain the 
66 kDa isoform; the level is highest in PND42 ERα+/+extracts and lowest in 
PND42 ERα-/- extracts (Figure 7).                    
                                                             
A.        
                                
             
B.  
                     
Figure 7.  Western Blot Analysis of ERα Protein. A. PND1, PND4, PND7, 
and PND42 ERα wildtype (+/+), heterozygote (+/-), and homozygous mutant 
(-/-) were probed with ERα MC-20 antibody. B. Blots were reprobed with 
GAPDH as a loading control.   
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Whole mount indirect immunofluorescence was carried out to determine 
the localization of the ERα protein in wildtype CD1 strain neonatal ovaries.  The 
anti-ERα MC-20 antibody was used to detect ERα in CD-1 mouse ovaries at 
PND1, PND4, and PND7. Ovaries were also labeled with propidium iodide to 
visualize DNA (nuclei).  The ERα protein is not detected in oocytes or somatic 
cells at PND1, PND4 or PND7 (Figure 8).       
 
A. 
 
 
 
  
B. 
 
   
                                                                                                                               
 
C. 
 
 
                                                                                                               
                                                                                     
Figure 8.  Detection of ERα Protein Using MC-20 Antibody.  
A. In staining of PND1 ovaries, ERα exhibits non-specific 
staining. B. PND4 exhibits non-specific staining. C. PND7 
exhibits non-specific staining. 
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Cyst Breakdown in ERα Mutant Mice 
 Estrogen treatment has been implicated in aberrant cyst breakdown in 
neonatal mice, suggesting that estrogen signaling has a role in cyst breakdown 
(Chen et al., 2007).  Neonatal mice treated with genistein, an estrogen-like 
compound found in soybeans, exhibit multiple oocyte follicles (MOFs) in ovaries 
as adults (Jefferson et al., 2002).  ERα knockout mice treated with genistein 
exhibit MOFs, while ERβ knockout mice do not (Jefferson et al., 2002).   This 
result implies that genistein signals through ERβ.  However, both ERα and ERβ 
agonists can inhibit cyst breakdown (Chen and Pepling, in preparation).  This 
implies that ERα as well as ERβ may be involved in cyst breakdown.  To 
determine the role of ERα in cyst breakdown and oocyte development, ERα+/+, 
ERα+/-, and ERα-/- mice were examined at PND1, PND4, and PND7.  Cyst 
breakdown was determined by comparing the number of oocytes in cysts to the 
number of single oocytes.  The average percentage of single oocytes increased 
during the seven days of development as expected in all genotypes, indicating that 
the process of cyst breakdown was occurring (Figure 9).  The single oocyte 
percentage was elevated in ERα+/-, and ERα-/- mice as compared to ERα+/+ at 
PND1, however, it was determined that this difference was not statistically 
significant (Figures 10).    There is no significant difference in cyst breakdown 
across the genotypes at PND4 (Figure 11).  However, there is a slight decrease in 
single oocyte percentage in ERα-/- ovaries, but this is not statistically significant.  
Thus, cyst breakdown occurred similarly across genotypes at PND4. At PND7, 
ERα+/- and ERα-/- ovaries had an increased percentage of single oocytes and this 
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difference was statistically significant (Figure 12). Thus, cyst breakdown appears 
to be accelerated at PND7. 
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Figure 9.  Summary of Cyst Breakdown at PND1, PND4, and PND7 in ERα+/+, 
ERα+/-, and ERα-/- mice. A rise in single oocyte percentage is indicative of cyst 
breakdown from PND1 to PND7. * indicates a statistically significant difference 
between the genotypes with p<0.05 considered statistically significant. N= 7-40 
sections in 1-5 ovaries. 
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PND1 Cyst Breakdown in ER Alpha Mutants
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Figure 10.  Cyst Breakdown at PND1 in ERα+/+, ERα+/-, and ERα-/- mice. 
There is more cyst breakdown in ERα+/- and ERα-/- at PND1 as compared 
with to ERα+/+, but this is not statistically significant.  N= 72 sections in 
9 ovaries (3 per genotype). 
Figure 11.  Cyst Breakdown at PND4 in ERα+/+, ERα+/-, and ERα-/- mice.  
There is no statistical significance difference between cyst breakdown 
between these three genotypes at PND4. N= 12-40 sections in 2-5 
ovaries 
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PND7 Cyst Breakdown in ER Alpha Mutants
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Total Oocyte Numbers in ERα Mutants   
 The total number of oocytes per confocal section was determined for 
ERα+/+, ERα+/-, and ERα-/- at PND1, PND4, and PND7 to establish whether ERα 
has a role in oocyte survival.  At PND1, there was higher average total oocyte 
number in all three genotypes, than at PND4 and PND7 (Figure 13).  PND4 and 
PND7 had lower average total oocyte numbers, showing a decline of oocyte 
number during the seven days of development, which normally occurs at this 
Figure 12.  Cyst Breakdown at PND7 in ERα+/+, ERα+/-, and ERα-/- mice. Cyst 
breakdown is elevated in PND7 in ERα+/- and ERα-/- resulting in a higher single 
oocyte percentage. Differences between genotypes were statistically significant.       
* indicates statistical significance where p<0.05. N= 7-40 sections in 1-5 ovaries. 
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time.  Although there were variations in oocyte number at PND1, PND4, and 
PND7, no differences were determined to be statistically significant.  
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Figure 13.  Total Number of Oocytes at PND1, PND4, and PND7 in ERα+/+, ERα+/-, 
and ERα-/- mice.  Differences between genotypes were not statistically significant. N= 
7-40 sections in 1-5 ovaries. 
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Follicle Development in ERα Mutants 
 To determine if ERα had a significant role in follicle development, 
oocytes collected at PND1, PND4, and PND7 were assessed using confocal 
microscopy.  For each confocal section, oocytes were classified as primordial, 
primary, or secondary follicles (Figure 14).  At PND1, most oocytes were 
unassembled, and the oocytes that were enclosed by granulosa cells were in 
primordial follicles.  There was no significant difference in development across 
all stages and genotypes at PND1 (Figure 15). Likewise, there was no significant 
difference in development across all stages and genotypes at PND7 (Figure 17). 
In contrast, ERα+/- and ERα-/- primordial follicle development was 
different from ERα+/+ at PND4 (Figure 16). ERα+/- has a slightly lower number of 
oocytes in primordial follicles than did wildtype, but this is not statistically 
significant. However, ERα-/- had considerably more oocytes in primordial follicles 
than did the other genotypes. Also, oocytes from ERα-/- mice did not develop past 
the primordial follicle stage, suggesting that they arrested in this phase of 
development and this difference is statistically significant. Primary and secondary 
follicle development at PND1 and PND7 exhibited no significant difference 
between the genotypes. 
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Figure 14.  Stages of Follicle Development. Oocytes with connecting 
cytoplasm are classified as unassembled (cysts). Primordial follicles 
consist of one oocyte and a single layer of flattened granulosa cells. As 
these follicles mature the oocyte increases in volume and its surrounding 
layer of granulosa cells become more cuboidal in shape. Granulosa cells 
increase in number. At this point, the follicle is considered primary. The 
oocyte continues to develop into a secondary follicle, denoted by more 
than one layer of granulosa cells. 
 33 
0
10
20
30
40
50
60
70
80
90
100
Primordial Primary Secondary
Follicles
Pe
rc
en
t O
o
cy
te
s
(+/+)
(+/-)
(-/-)
 
 
 
0
10
20
30
40
50
60
70
80
90
100
Primordial Primary Secondary
Follicles
Pe
rc
en
t O
o
cy
te
s
(+/+)
(+/-)
(-/-)
 
 
Figure 15.  Follicle Development at PND1 in ERα+/+, ERα+/-, and ERα-/- mice. 
Difference between genotypes was not statistically significant. N= 72 sections in 9 
ovaries. 
Figure 16.  Follicle Development at PND4 in ERα+/+, ERα+/-, and ERα-/- mice.  * 
indicates statistically significant difference between the genotypes with p<0.05. N= 
12-40 sections in 2-5 ovaries. 
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Figure 17.  Follicle Development at PND7 in ERα+/+, ERα+/-, and ERα-/- mice. 
Differences between the genotypes were not statistically significant. N= 7-40 
sections in 1-5 ovaries. 
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DISCUSSION 
 
 Estrogen signals through receptor-mediated pathways. Disruption of 
pathways results in abnormalities in the adult (Jefferson et al., 2002) and neonatal 
reproductive systems (Chen et al., 2007). However, it is not known whether ERα 
plays an integral role in normal oocyte development or if the occurrence of these 
abnormalities in mice may be an indirect effect of a disruption in this receptor.  
Thus, the main objectives of this research were to establish whether ERα was 
expressed in neonatal ovaries and if so where, and to examine ERα homozygous 
mutant mice for defects in neonatal cyst breakdown, oocyte survival and follicle 
development at PND1, PND4, and PND7. 
 The ERα protein was detected in neonatal ovaries using protein Western 
blot analyses. The expected size of the “classical” full-length ERα is 66 kDa 
(Pendaries et al., 2002).  A protein of this size was detected in PND1, PND4, 
PND7, and PND108 tissue samples by Western blotting (Figure 6).   However, 
there were also polypeptides detected at 55kDa and 46kDa in PND1, PND4, and 
PND7. ERα is known to have three isoforms, the 55 kDa and 46 kDa isoforms 
being ERα mRNA splice variants (Pendaries et al., 2002).  They are all detected 
by the ERα MC-20 antibody, which explains why these other isoforms were 
detected (Pendaries et a., 2002).   Likewise, the MCF7 human ERα positive 
control exhibited a band at 46 kDa.  Therefore, all of the mouse protein extracts 
contained ERα, indicating that the protein was in fact expressed at the 
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developmental stages assayed.  There was also protein detected at approximately 
30 kDa at PND108, which may have been due to protein degradation.  
 A second Western blot was run to determine whether the ERα protein 
level was reduced in ERα+/- ovaries and absent from ERα-/- ovaries.  Tissue 
samples from PND42 (adult) ERα+/+, ERα+/-, and ERα-/- mice were collected and 
run on the western with the original tissue samples from PND1, PND4, and PND7 
(Figure 7).  As was expected, the ERα+/+ tissue sample showed the strongest band 
and ERα+/- showed a weaker band.  It was initially hypothesized that the ERα 
protein would not be detected in the ERα-/- tissue sample due to the fact that the 
gene had been knocked out.  However, the ERα protein was detected, though very 
weakly. This may have occurred because the ERα-/- mouse may not have been a 
full knockout and thus may have retained some of its protein activity.  
 In the second Western blot the concentration of the secondary antibody 
goat anti-rabbit was increased from 1:10,000 to 1:15,000.  This was done in 
efforts to minimize the appearance of background or nonspecific labeling. Based 
on the results of the second Western blot, the concentration change did not have 
the desired effects because portions of the Western were still blurry.  Further 
analysis of the ERα protein will have to be carried out to alleviate issues with 
concentrations, full ERα knockout protein expression, and to increase overall 
understanding of the ERα protein.  
ERα localization was also investigated in this study.  ERα is expressed by 
theca cells in the adult ovary.  The ERα protein is detected as early as PND1 by 
Western blotting.  However, the results of immunocytochemistry only show non-
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specific staining in the PND1, PND4, and PND7 ovary.  Due to the confirmed 
expression via Western blot, it was assumed that the concentration of the MC-20 
antibody needed to be increased to exhibit results that mirror that of the Western 
blot analysis, or that the protein is expressed at very low levels. 
 ERα protein activity was further analyzed in the assessment of oocyte 
development using mutants lacking ERα.  The total number of oocytes per 
confocal section was examined to determine if there were significant differences 
in oocyte survival across all three genotypes at each age of development.  There 
was an overall loss of oocytes across all genotypes, indicating that germ cell loss 
is a regulated process that occurs in ERα+/+, ERα+/-, and ERα-/- over the seven 
days of development normally (Pepling and Spradling, 2001).  However, there 
was a significantly lower amount of oocytes in ERα+/- and ERα-/- than there was in 
ERα+/+ animals, in all three days of development.  This would suggest that 
reduction in the level of ERα may accelerate oocyte loss. 
 Single oocyte percentage was examined to determine if ERα had a role in 
cyst breakdown. PND4 and PND7 showed the highest percentages of single 
oocytes.  This confirms that cyst breakdown did occur and that by PND7 the 
majority of oocytes were single.  There did not seem to be a significant difference 
in single oocyte percentage between the genotypes at PND4.  However, there was 
an elevated percentage of single oocytes in ERα+/- and ERα-/- relative to ERα+/+ 
animals at PND1 and PND7.  This suggests that at PND1 and PND7 cyst 
breakdown is elevated.  However, the results at PND4 are not consistent with this 
interpretation.  
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Past research using estradiol treatment on neonatal mice suggested that 
estrogen signaling had a major role in preventing or delaying cyst breakdown 
(Chen et al., 2007).  Thus it was originally postulated that ERα was necessary for 
the maintenance of cysts, and mice lacking this receptor would have accelerated 
cyst breakdown.  The results presented here are inconclusive.  One possible 
interpretation is as follows: perhaps ERα activity is important for the maintenance 
of cysts at PND1, thus its absence serves to speed up cyst breakdown.  It is 
possible that by PND4, ERβ compensates for the lack of ERα activity and cyst 
breakdown rates begin to normalize, but by PND7 ERβ is no longer able to 
compensate and the increase in cyst breakdown returns as a result.  Ultimately the 
results of this research are not conclusive enough to provide true evidence for 
these hypotheses, and further research will need to be done to determine whether 
ERα truly plays a role in cyst breakdown. 
In the examination of ERα’s role in follicle development, there was no 
difference in follicle development across all genotypes at PND1 and PND7.  At 
PND4 there seemed to be a lower number of primordial follicles in the ERα+/- 
heterozygote than the ERα+/+ wildtype and ERα-/- mutant mice.  There is also a 
considerably higher percentage of oocytes in primordial follicles in ERα-/- mice 
than ERα+/- and ERα+/+ mice.  Strikingly, there are no primary or secondary 
follicles in ERα-/-.  This indicates that there is an inhibition of primordial follicle 
development and the follicles can not advance to the primary stage as a result in 
ERα-/- at PND4.  Again, further research will be needed to support this idea. 
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There seemed to be the most noticeable differences in oocyte development 
at PND4.  However, since these trends were not continuous throughout PND1 and 
PND7, it is difficult to derive concrete conclusions.  A number of factors may 
have contributed to this.  Determining the stage of oocyte development was often 
an issue when it came to distinguishing a definite stage for oocytes that were 
transitioning between phases of follicle development.  The creation of a consistent 
and universal method of making this determination and counting oocytes 
according to it would probably help to alleviate this problem.  
Technical difficulties may have played a role in discrepancies in data 
collection.  An inability to accurately genotype collected ovaries via PCR analysis 
delayed the research process, leaving less time to analyze those ovaries initially 
collected once the PCR problem was solved.  This also left less time to collect 
more ovaries for a consistent sample size across genotypes. In particular, it was 
difficult to acquire as many homozygous mutant ovaries for analysis as 
heterozygous ovaries at PND1 and PND4.  It was also difficult to acquire 
wildtype ovaries for all three ages.  Thus, smaller sample sizes for homozygous 
mutant and wildtype ovaries may have contributed to inconclusive results.  There 
were also technical difficulties with antibody staining, due to a lack of germ cell 
staining, it was difficult to distinguish developmental stages. More accurate 
results will require the collection of a larger and consistent number of ovaries 
from each genotype and developmental stage. 
The purpose of this research was to further investigate how cyst 
breakdown, cell death, and follicle development are regulated in the neonatal 
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ovary.  It is known that these processes occur in all mammals, including humans 
(Pepling, 2006).  It is our hope that research in mice will help us to further 
uncover the mechanisms involved in these processes.  Since the pool of oocytes 
that one will have throughout her entire life is designated at birth, it is our hope 
that this research sheds more light on how this pool is established.  Likewise, 
estrogen has a major role in the development of these germ cells.  With the 
discovery of how endocrine disruption can have a deleterious effect on 
reproductive ability, coupled with the appearance of hormones in just about every 
product we ingest, it is imperative that these type of studies be carried out so 
scientists have a better understanding of how to combat their possible negative 
effects.  Thus, further research is necessary to create preventative and corrective 
methods for disorders in estrogen signaling and ultimately establishing an 
increased understanding of germ cell development as a whole. 
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Capstone Summary 
 
Reproductive ability is an issue that has maintained importance in the 
world. Thus, as with most issues, scientists are working diligently to study and 
form a better understanding of how the reproductive system operates. In females, 
this study is mainly based around the capacity to produce viable oocytes or eggs. 
In the mouse model system, the production of these eggs begins well before birth, 
where precursor cells called primordial germ cells divide a number of times by 
mitosis. Mitosis is the process by which cells in the body divide to create 
duplicates of themselves. After these primordial germ cells, or egg precursors, 
divide they form cysts, or clusters of cells that are still connected because of 
incomplete severance after divisions. Eventually, after birth in mice, a number of 
cells begin to die via programmed cell death (also known as apoptosis) and these 
cysts begin to break down. The end result is what is known as a primordial 
follicle, or one oocyte/egg surrounded by a number of flattened supporting cells 
called granulosa cells. This step is of extreme importance and interest because the 
pool of primordial follicles a female has after birth is all she will have for the rest 
of her life. This research has looked into the mechanisms involved in the cyst 
breakdown that leads to the formation of this primordial follicle pool, the ability 
of oocytes to survive despite programmed cell death, and how follicle 
development continues after primordial follicle formation.  
 It is well-known that estrogen has many roles in sexual development in 
females. Therefore, it is not difficult to assume that it may have a role in the 
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individual stages of egg development. Estrogen is a steroid hormone. There are 
three types of estrogen that circulate in the body called estradiol, estriol, and 
estrone. Estradiol is the most prevalent form. Estrogen operates through two types 
of protein called estrogen receptors located in the nucleus of a cell. These 
receptors are specifically called estrogen receptor alpha (ERα) and estrogen 
receptor beta (ERβ). In order for estrogen to carry out its effects, it must first bind 
to these receptors. The estrogen-bound receptors then homodimerize, meaning 
that two of the same type of receptor (i.e. two ERαs) bind to each other, and then 
the homodimer binds to a specific part of the DNA that recognizes this complex 
called an estrogen response element (ERE). After binding to the DNA, the 
receptor-estrogen complex recruits helpers called co-regulators to transcribe, or 
read, the DNA and produce RNA. Ultimately, the RNA is translated into proteins 
that will carry out estrogen’s effects throughout the body. 
 Previous research has shown that estrogen’s mechanism of action can be 
disrupted and lead to malfunctions in normal cyst breakdown, egg production, and 
development. When neonatal (baby) mice were treated with genistein, an 
estrogen-like compound (behaves like estrogen in the cell) found in soy plants, 
they developed multiple oocyte follicles (MOFs) in adulthood. Throughout the 
female life, eggs go through a number of stages of development where the egg is 
encased in supporting cells and called a follicle. Follicle development, prior to 
ovulation, normally proceeds from primordial follicle, to primary, and then 
secondary follicle, where the shape of the granulosa cells becomes more cuboidal 
and their number increases, and the oocyte itself gets larger with each stage. 
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MOFs are thought to be the result of incomplete cyst breakdown that leads to 
more than one egg per follicle. Another study was done treating neonatal (baby) 
mouse ovaries with estradiol (excess estrogen that operates through both 
receptors). Researchers found that cyst breakdown was inhibited; the oocytes 
remain in cysts instead of separating breaking down into single oocytes in 
primordial follicles. All of this tells us that estrogen has a definite effect on cyst 
breakdown and since it works through ERα and ERβ, they too have a role in this 
process. 
 Both ERα and ERβ have been shown to be important in the body. Initially, 
scientists thought that ERα was the only estrogen receptor, but recent research has 
shown that ERβ is also an estrogen receptor. ERβ is found in the ovary, 
epididymis, prostate, lung, and hypothalamus. ERα is found throughout the body 
in many areas including the ovary.  Our research is particularly focused on these 
receptors’ effects in the ovary when they are working normally and also on the 
consequences of loss of ERα activity.  ERβ activity in the ovary is found in the 
granulosa cells that surround the oocyte (egg). Research has shown that when this 
receptor’s activity is disrupted, meaning that it no longer works or is knocked out 
in mice, the mice develop normally, but have smaller litters. However, my 
research is focused on the role of ERα. ERα is expressed in other supporting cells 
called theca cells, which line the granulosa cells. If the ERα receptor is disrupted, 
past research showed that adult mice are infertile, lack corpus lutea (which 
secretes hormones that support implantation of the egg into the uterus after 
fertilization), and have hemorrhagic (bleeding) and cystic (follicles that fail to 
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ovulate) follicles. Although studies tell us a great deal about ERα in adult and 
treated neonatal mice ovaries, there has been no research done on the role of ERα 
in normal neonatal and the mutant phenotypes of mice lacking working ERα.   
 As a result of the lack of information on neonatal mice lacking ERα, my 
research is focused on the role of ERα in oocyte development in these mice. Since 
lacking this receptor is shown to have such severe effects in adult mice, it was my 
hope to establish whether these effects could be detected earlier on in 
reproductive development. This research attempted to answer two questions: 1) is 
ERα expressed (present) in normal neonatal ovaries and if so where; and 2) what 
are the effects on cyst breakdown, oocyte number (survival), and follicle 
development when ERα is absent. 
 A number of scientific methods were used to answer these questions. Mice 
from a normal strain (no abnormalities in ERα activity) called CD-1 was used to 
answer the first question. A technique called Western blot analysis was used to 
test whether the ERα protein was present in the neonatal ovary in these mice. 
Ovaries were collected from mice at 1, 4, and 7 days after birth (called PND1, 
PND4, and PND7 from now on), which is the time when cyst breakdown, cell 
apoptosis, and primordial follicle development occurs. To find out if ERα was 
localized to the theca cells as it is in adult mice ovaries, were treated with an 
antibody against the ERα protein called MC-20 and a secondary antibody 
equipped with a fluorescent tag that would label MC-20.  
Mice that were purchased as ERα heterozygotes (having one normal copy 
and one defective copy) and bred to produce mice with two normal copies of 
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ERα, one normal/one defective, and two defective copies were also used to 
answer the second question. Ovaries were collected from these mice at PND1, 
PND4, and PND7 as well. Polymerase chain reactions (PCRs), which amplify 
specific regions of DNA (the ERα gene in this case) were used to detect normal 
(working) or mutant (disrupted) copies of the gene. The amplification product was 
then used visualized using gel electrophoresis, a technique which uses UV light to 
detect fragments of DNA. This method was used to determine the genotype of 
each mouse. The genotype is the genetic profile, indicating the presence of genes. 
In this case, if a mouse has two normal copies of the ERα gene it is known as ERα 
wildtype (normal), if it has one normal and one defective copy it is ERα 
heterozygous, if it has two defective copies the mouse is considered ERα mutant. 
Once it was known which type of mouse the ovaries came from, a fluorescent 
marker was used to label the oocytes/eggs in these ovaries. Pictures were then 
taken of the ovaries using a fluorescent microscope called a confocal microscope. 
Oocytes in these pictures were counted and analyzed to see if there were 
differences in cyst breakdown, oocyte survival, and follicle development in the 
wildtype, heterozygote, and mutant ERα mice.  
 The results of this study were as follows. A technique called Western blot 
analysis indicated that ERα was present in neonatal ovaries. However, labeling 
ovaries with the fluorescent tag did not show any ERα present, suggesting that the 
expression was very low at PND1, PND4, and PND7. By analyzing the pictures 
that were taken of the ovaries from the ERα wildtype (normal), ERα 
heterozygous, and ERα mutant mice, we were able to see limited differences. Cyst 
 48 
breakdown increased over the seven days of development as it should have for all 
three genotypes. However, the rate that the cysts were breaking down was faster 
in the heterozygous (having partial ERα activity) and mutant (having no ERα 
activity) mice, than it was in normal mice (having fully active ERα) at the PND7. 
This indicates that ERα may have a role in the normal rate of cyst breakdown. 
There was no significant difference in oocyte survival between the different types 
of mice in all seven days of development, suggesting that ERα does not have a 
role in oocyte survival or programmed cell death. In this study, follicle 
development was found to proceed normally in all types of mice at PND1 and 
PND7. However, at PND4, the ERα mutant mice were all at the primordial 
follicle stage. Normally by this time some oocytes have moved into the primary 
and secondary follicle stage. However, this is not the case in the ERα mutants. 
This indicates that at PND4, mutant mice were arrested in their development and 
could not develop past the primordial follicle stage. Thus, ERα may have a role in 
follicle development as well.  
 Overall, this research is important for a better understanding of how 
reproductive development works in the ovary. Many of the conclusions made will 
need further research to support them because of small sample sizes (small 
numbers of ovaries analyzed) and inconsistent oocyte counting methods. 
However, this research does contribute information about the role of ERα, which 
was not previously known. Hopefully, this will be able to be used by future 
researchers to fully explain how estrogen operates in the body. Ultimately, 
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scientists hope to utilize this and other research in the field of reproductive 
development to properly diagnose and treat human infertility.  
 
